fbpx Skip to main content

Member's Profile

OncoMyx Therapeutics

445 N 5th St
Phoenix,   Arizona
United States
Membership Info
Membership Type: Industry
Membership Since: 2019
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About OncoMyx Therapeutics
Biotech Company
OncoMyx Therapeutics, a startup launched from Professor Grant McFadden’s laboratory at Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer.
Related News
No related news posted by this Member